Browsing by Author "Dias, Alberto C. P."
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- Development of polymeric nanoparticles containing neuroprotective compounds of Hypericum perforatumPublication . Oliveira, Ana; Pinho, Cláudia; Fonte, Pedro; Sarmento, Bruno; Dias, Alberto C. P.Neurodegenerative process involves several mechanisms. Hypericum perforatum extracts have been used for their antidepressive effects. A selected fraction (HP) of these extracts proved to be neuroprotective.
- Neuroprotective Activity of Hypericum perforatum and Its Major ComponentsPublication . Oliveira, Ana Isabel; Pinho, Cláudia; Sarmento, Bruno; Dias, Alberto C. P.Hypericum perforatum is a perennial plant, with worldwide distribution, commonly known as St. John’s wort. It has been used for centuries in traditional medicine for the treatment of several disorders, such as minor burns, anxiety, and mild to moderate depression. In the past years, its antidepressant properties have been extensively studied. Despite that, other H. perforatum biological activities, as its neuroprotective properties have also been evaluated. The present review aims to provide a comprehensive summary of the main biologically active compounds of H. perforatum, as for its chemistry, pharmacological activities, drug interactions and adverse reactions and gather scattered information about its neuroprotective abilities. As for this, it has been demonstrated that H. perforatum extracts and several of its major molecular components have the ability to protect against toxic insults, either directly, through neuroprotective mechanisms, or indirectly, through is antioxidant properties. H. perforatum has therefore the potential to become an effective neuroprotective therapeutic agent, despite further studies that need to be carried out.
- Quercetin-biapigenin nanoparticles are effective to penetrate the blood–brain barrierPublication . Oliveira, Ana; Pinho, Cláudia; Sarmento, Bruno; Dias, Alberto C. P.Search for efficient therapeutic agents for central nervous system (CNS) disorders has been extensive. Nevertheless, blood-brain barrier (BBB) is an obstacle that prevents the majority of compounds to act in these diseases. It is, thus, of extreme relevance the BBB overcome, in order to deliver a drugs therapeutically active concentration to the action site, with the least losses and interaction with other organs, tissues, or cells. The present study aimed to investigate the potential protective effect of quercetin-biapigenin encapsulated into poly(Ɛ-polycaprolactone) (PCL) nanoparticles against t-BOOH-induced oxidative stress in several brain cell lines, as well as evaluate the permeability of those active molecules through an in vitro BBB model. The three cell lines under study (BV-2, hcmec/D3, and U87) presented different reactions to t-BOOH. In general, quercetin-biapigenin PCL-loaded nanoparticles were able to minimize compound toxicity they convey, regardless the cell line. Quercetin-biapigenin PCL-loaded nanoparticles (Papp of approximately 80 × 10-6 cm/s) revealed to be more permeable than free compounds (Papp of approximately 50 × 10-6 cm/s). As of our knowledge, this is the first report of quercetin-biapigenin PCL-loaded nanoparticle activity in brain cells. It is also the first determining its permeability through BBB, as an effective nanocarrier for brain delivery.